Display options
Share it on
Full text links
View full text

AY Deneka, Y Boumber, T Beck, EA Golemis - Cancers, 2019 - mdpi.com

Tumor-targeted drug conjugates as an emerging novel therapeutic approach in small cell lung cancer (SCLC).

community settings

Beck, Boumber, Deneka, Golemis

GSID: DH94nIFciBwJ

Excerpt

There are few effective therapies for small cell lung cancer (SCLC), a highly aggressive disease representing 15% of total lung cancers. With median survival< 2 years, SCLC is one …

Cited by